Assessments
We used the PHQ-9 [For the experimental and active control group participants, the PHQ-9 and GAD-7 were administered before the beginning of each module, after completing all the modules, and at the 90-day follow-up time point. The first PHQ-9 (administered before randomization, as it was an inclusion-exclusion criterion) and the first GAD-7 (administered after randomization but before the first module of the intervention) served as the baseline scores. For the waitlist control group, the PHQ-9 and GAD-7 were administered at baseline and after a 42-day interval (this interval was chosen to be at par with the expected intervention duration of approximately 6 weeks for completing the 6 modules in the experimental group). After submitting the 42-day assessments, the waitlisted participants were also given access to the intervention.